{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:37:28Z","timestamp":1775738248436,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T00:00:00Z","timestamp":1359331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11547-012-0914-7","type":"journal-article","created":{"date-parts":[[2013,1,27]],"date-time":"2013-01-27T22:48:56Z","timestamp":1359326936000},"page":"555-569","source":"Crossref","is-referenced-by-count":24,"title":["Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)","Terapia loco-regionale multimodale dell\u2019epatocarcinoma non resecabile con approccio single-step: termoablazione a radiofrequenza durante occlusione temporanea dell\u2019arteria epatica con catetere da PTA (BO-RFA) plus chemioembolizzazione arteriosa transcatetere (TACE)"],"prefix":"10.1007","volume":"118","author":[{"name":"HepatoCATT Group for the Multidisciplinary Management of HCC","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Iezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cesario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Siciliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Campanale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"De Gaetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Agnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Giuliante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Rapaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,28]]},"reference":[{"key":"914_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"D.M. Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"914_CR2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","volume":"37","author":"I. Ikai","year":"2007","unstructured":"Ikai I, Arii S, Okazaki M et al (2007) Report of the 17th Nationwide Followup Survey of Primary Liver Cancer in Japan. Hepatol Res 37:676\u2013691","journal-title":"Hepatol Res"},{"key":"914_CR3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00268-005-0249-9","volume":"30","author":"A. Sasaki","year":"2006","unstructured":"Sasaki A, Iwashita Y, Shibata K et al (2006) Improved long-term survival after liver resection for hepatocellular carcinoma in the modern era: retrospective study from HCV-endemic areas. World J Surg 30:1567\u20131578","journal-title":"World J Surg"},{"key":"914_CR4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/bjs.5335","volume":"93","author":"X.P. Chen","year":"2006","unstructured":"Chen XP, Qiu FZ, Wu ZD et al (2006) Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 93:600\u2013606","journal-title":"Br J Surg"},{"key":"914_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000217921.28563.55","volume":"244","author":"K. Taura","year":"2006","unstructured":"Taura K, Ikai I, Hatano E et al (2006) Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 244:265\u2013273","journal-title":"Ann Surg"},{"key":"914_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000658-199810000-00005","volume":"228","author":"G.B. Klintmalm","year":"1998","unstructured":"Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 228:479\u2013490","journal-title":"Ann Surg"},{"key":"914_CR7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000658-200204000-00012","volume":"235","author":"S. Roayaie","year":"2002","unstructured":"Roayaie S, Frischer JS, Emre SH et al (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533\u2013539","journal-title":"Ann Surg"},{"key":"914_CR8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","volume":"131","author":"K. Takayasu","year":"2006","unstructured":"Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461\u2013469","journal-title":"Gastroenterology"},{"key":"914_CR9","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","volume":"362","author":"J.M. Llovet","year":"2003","unstructured":"Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907\u20131917","journal-title":"Lancet"},{"key":"914_CR10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0929-8266(01)00129-X","volume":"13","author":"T. Livraghi","year":"2001","unstructured":"Livraghi T (2001) Guidelines for treatment of liver cancer. Eur J Ultrasound 13:167\u2013176","journal-title":"Eur J Ultrasound"},{"key":"914_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1040-8428(02)00213-5","volume":"47","author":"G. Marin-Hargreaves","year":"2003","unstructured":"Marin-Hargreaves G, Azoulay D, Bismuth H (2003) Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 47:13\u201327","journal-title":"Crit Rev Oncol Hematol"},{"key":"914_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2002.01149.x","volume":"16","author":"A.M. Alsowmely","year":"2002","unstructured":"Alsowmely AM, Hodgson HJ (2002) Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 16:1\u201315","journal-title":"Aliment Pharmacol Ther"},{"key":"914_CR13","first-page":"47","volume":"49","author":"F. Durand","year":"2002","unstructured":"Durand F, Belghiti J (2002) Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 49:47\u201352","journal-title":"Hepatogastroenterology"},{"key":"914_CR14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00000658-200204000-00004","volume":"235","author":"R.T. Poon","year":"2002","unstructured":"Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon\u2019s perspective. Ann Surg 235:466\u2013486","journal-title":"Ann Surg"},{"key":"914_CR15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiology.210.3.r99fe40655","volume":"210","author":"T. Livraghi","year":"1999","unstructured":"Livraghi T, Goldberg SN, Lazzaroni S et al (1999) Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 210:655\u2013661","journal-title":"Radiology"},{"key":"914_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cncr.20892","volume":"15","author":"R. Tateishi","year":"2005","unstructured":"Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 15:1201\u20131209","journal-title":"Cancer"},{"key":"914_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000315239","volume":"78","author":"M. Kudo","year":"2010","unstructured":"Kudo M (2010) Radiofrequency ablation for hepatocellular carcinoma: update review in 2010. Oncology 78:113\u2013124","journal-title":"Oncology"},{"key":"914_CR18","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"J.M. Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"914_CR19","first-page":"356","volume":"14","author":"M. Biolato","year":"2010","unstructured":"Biolato M, Marrone G, Racco S et al (2010) Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? Eur Rev Med Pharmacol Sci. 14:356\u2013362","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"914_CR20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"J.M. Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"914_CR21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejso.2007.02.006","volume":"34","author":"G.S. Liao","year":"2008","unstructured":"Liao GS, Yu CY, Shih ML et al (2008) Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. EJSO 34:61\u201366","journal-title":"EJSO"},{"key":"914_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.2471070818","volume":"247","author":"K. Yamakado","year":"2008","unstructured":"Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260\u2013266","journal-title":"Radiology"},{"key":"914_CR23","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.299.14.1669","volume":"299","author":"B.Q. Cheng","year":"2008","unstructured":"Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669\u20131677","journal-title":"JAMA"},{"key":"914_CR24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00330-005-0029-9","volume":"16","author":"A. Veltri","year":"2006","unstructured":"Veltri A, Moretto P, Doriguzzi A et al (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable nonearly hepatocellular carcinoma (HCC). Eur Radiol 16:661\u2013669","journal-title":"Eur Radiol"},{"key":"914_CR25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jvir.2008.10.019","volume":"20","author":"H. Takaki","year":"2009","unstructured":"Takaki H, Yamakado K, Uraki J et al (2009) Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol 20:217\u2013224","journal-title":"J Vasc Interv Radiol"},{"key":"914_CR26","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","volume":"42","author":"J. Bruix","year":"2005","unstructured":"Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208\u20131236","journal-title":"Hepatology"},{"key":"914_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jvir.2009.04.011","volume":"20","author":"S.N. Goldberg","year":"2009","unstructured":"Goldberg SN, Grassi CJ, Cardella JF et al (2009) Society of Interventional radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:377\u2013390","journal-title":"J Vasc Interv Radiol"},{"key":"914_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiology.217.1.r00se02119","volume":"217","author":"S. Rossi","year":"2000","unstructured":"Rossi S, Garbagnati F, Leoncini R et al (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217:119\u2013126","journal-title":"Radiology"},{"key":"914_CR29","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/cncr.10966","volume":"95","author":"T. Yamasaki","year":"2002","unstructured":"Yamasaki T, Kurokawa F, Shirahashi H et al (2002) Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Cancer 95:2353\u20132360","journal-title":"Cancer"},{"key":"914_CR30","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.RVI.0000136829.36643.ED","volume":"15","author":"K. Ahrar","year":"2004","unstructured":"Ahrar K, Newmann RA, Pang J et al (2004) Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol 15:901\u2013905","journal-title":"J Vasc Interv Radiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-012-0914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-012-0914-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-012-0914-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:32:55Z","timestamp":1559392375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-012-0914-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,28]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["914"],"URL":"https:\/\/doi.org\/10.1007\/s11547-012-0914-7","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,28]]}}}